Bulletin Updates
Shaily’s pen injector platform enters generic Semaglutide combination product – 21 May 2026
May 21, 2026
Shaily’s ShailyPen Neo platform is part of a generic Semaglutide injection launched in Canada.
The product has Health Canada approval, India approval and USFDA tentative approval.
The full story is for subscribers. Log in to read it, or start a free trial.
Log in Start a free trial »
Log in Start a free trial »